ResMed Takes CPAP Patent Fight Back To ITC
This article was originally published in The Gray Sheet
Executive Summary
The continuous positive airway pressure manufacturer lost a 2013 patent case against BMC when its humidifier patent was ruled invalid due to prior art, but it’s now filed a fresh claim asserting a new and more narrowly tailored patent.
You may also be interested in...
Agency Takes On ResMed Sleep Mask Complaint
The US International Trade Commission has agreed to investigate ResMed’s complaint that a New Zealand company and its American subsidiaries are illegally importing and selling sleep masks that violate ResMed patents.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.